← Back to catalogue

DImension Vista® High Sensitivity CRP Control H (high)

FDA UDI

Class I (US FDA UDI)

by Siemens Healthcare Diagnostics Products Ltd

Identity

Trade Name
DImension Vista® High Sensitivity CRP Control H (high) FDA UDI
Generic Name
C-reactive protein (CRP) IVD, control FDA UDI
Device Name
For use as an assayed intralaboratory control for assessment of precision and analytical bias in the determination of the hsCRP method on the Dimension Vista® System FDA UDI
Model / Reference
10445930 FDA UDI
Description
For use as an assayed intralaboratory control for assessment of precision and analytical bias in the determination of the hsCRP method on the Dimension Vista® System FDA UDI

Identifiers

Catalog Number
KC757 FDA UDI
Primary DI / UDI-DI
00842768006432 FDA UDI
510(k) Number
K061802 FDA UDI
FDA Product Code
JJY FDA UDI
GMDN Term
C-reactive protein (CRP) IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: C-reactive protein (CRP) IVD, control

DImension Vista® High Sensitivity CRP Control H (high) by Siemens Healthcare Diagnostics Products Ltd — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as C-reactive protein (CRP) IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 0239debc-1dcd-415e-89b9-0eb5eaf4d2f0 37 fields · synced Jun 8, 2026